Brief: Mubadala Investment Co PJSC Reports Stake In SpaceX, Pfizer, Adobe
BRIEF-Mubadala Investment Co PJSC Reports Stake In SpaceX, Pfizer, Adobe Nov 16 (Reuters) - Mubadala Investment Co PJSC:
MUBADALA INVESTMENT CO PJSC REPORTS SHARE STAKE OF 107,828 CLASS A SHARES IN SPACEX - SEC FILING
MUBADALA INVESTMENT CO PJSC DISSOLVES SHARE STAKE IN BRISTOL-MYERS SQUIBB CO - SEC FILING
MUBADALA INVESTMENT CO PJSC REPORTS SHARE STAKE OF 208,465 SHARES IN PFIZER INC - SEC FILING
MUBADALA INVESTMENT CO PJSC REPORTS SHARE STAKE OF 23,074 SHARES IN ADOBE INC - SEC FILING
MUBADALA INVESTMENT CO PJSC DISSOLVES SHARE STAKE IN LAM RESEARCH CORP - SEC FILING
MUBADALA INVESTMENT CO PJSC CUTS SHARE STAKE IN MICRON TECHNOLOGY INC BY 57.3% TO 19,389 SHARES - SEC FILING
MUBADALA INVESTMENT CO PJSC CUTS SHARE STAKE IN CVS HEALTH CORP BY 21.6% TO 128,447 SHARES - SEC FILING
MUBADALA INVESTMENT CO PJSC DISSOLVES SHARE STAKE IN NEWMONT CORP - SEC FILING
MUBADALA INVESTMENT CO PJSC DISSOLVES SHARE STAKE IN BARRICK MINING - SEC FILING
MUBADALA INVESTMENT CO PJSC CUTS SHARE STAKE IN PALANTIR TECHNOLOGIES INC BY 23.0% TO 73,635 CLASS A SHARES - SEC FILING
MUBADALA INVESTMENT CO PJSC: CHANGE IN HOLDINGS ARE AS OF SEPT. 30, 2026, AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF JUNE 30, 2026
SOURCE FOR THE QUARTER ENDED SEPT 30, 2026: https://bit.ly/4j1fhON
SOURCE FOR THE QUARTER ENDED JUNE 30, 2026: https://bit.ly/4AzmCMo
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bristol-Myers Squibb
See all newsEvotec rises after second FDA IND acceptance in Bristol Myers Squibb partnership
AbbVie expands bispecific cancer med push with up to $2.5 billion deal with Germany's Disco
Bristol's schizophrenia drug helps Alzheimer's-related psychosis symptoms, preliminary data shows
Brief: Bristol Myers Squibb Presents First Clinical Data From Two Phase 3 Studies In The Adept Program Evaluating Karxt For Psychosis Associated With Alzheimer’S Disease
Brief: Sichuan Biokin Pharmaceutical's Unit Receives Milestone Payment From Bristol-Myers Squibb